Prevalence and clinical outcomes of polycythemia vera and essential thrombocythemia with hydroxyurea resistance or intolerance

Prevalence and clinical outcomes of polycythemia vera and essential thrombocythemia with hydroxyurea resistance or intolerance

Introduction To determine the prevalence, clinical outcomes, and factors associated with hydroxyurea (HU) resistance or intolerance among polycythemia vera (PV) and essential thrombocythemia (ET) patients.Methods This study was a retrospective cohort study including PV and ET patients diagnosed by W...

Full description

Bibliographic Details
Main Authors: Kittitat Chiaranairungrot, Komkrich Kaewpreechawat, Chanwit Sajai, Narueporn Pagowong, Nissa Sukarat, Pokpong Piriyakhuntorn, Thanawat Rattanathammethee, Sasinee Hantrakool, Chatree Chai-Adisaksopha, Adisak Tantiworawit, Lalita Norasetthada, Ekarat Rattarittamrong
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Hematology
Subjects:
Polycythemia vera
essential thrombocythemia
hydroxyurea
hydroxyurea resistance
hydroxyurea intolerance
myeloproliferative neoplasms
Online Access:https://www.tandfonline.com/doi/10.1080/16078454.2022.2105582

Internet

https://www.tandfonline.com/doi/10.1080/16078454.2022.2105582

Similar Items